X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-08 | EVLO | Bodmer Mark | CSO, Pres of R, D | S - Sale+OE | $0.33 | -3,163 | 25,732 | -11% | -$1,044 | |||||
| D | 2023-11-08 | EVLO | McHale Duncan | Chief Medical Officer | S - Sale+OE | $0.33 | -3,103 | 16,984 | -15% | -$1,024 | |||||
| D | 2023-11-08 | EVLO | Gill Simba | Pres, CEO | S - Sale+OE | $0.33 | -172 | 17,758 | -1% | -$57 | |||||
| D | 2023-11-08 | EVLO | Thorell Marella | CFO | S - Sale+OE | $0.33 | -1,811 | 22,259 | -8% | -$598 | |||||
| D | 2023-11-02 | EVLO | Bodmer Mark | CSO, Pres of R, D | S - Sale+OE | $0.33 | -6,854 | 22,270 | -24% | -$2,262 | |||||
| D | 2023-11-02 | EVLO | McHale Duncan | Chief Medical Officer | S - Sale+OE | $0.33 | -6,854 | 13,587 | -34% | -$2,262 | |||||
| D | 2023-11-02 | EVLO | Thorell Marella | CFO | S - Sale+OE | $0.33 | -3,999 | 17,570 | -19% | -$1,320 | |||||
| D | 2023-09-28 | EVLO | Gill Simba | Pres, CEO | S - Sale+OE | $3.94 | -1,996 | 16,758 | -11% | -$7,864 | |||||
| D | 2023-08-08 | EVLO | Bodmer Mark | CSO, Pres of R, D | S - Sale+OE | $9.51 | -3,128 | 16,624 | -16% | -$29,747 | |||||
| D | 2023-08-08 | EVLO | Gill Simba | Pres, CEO | S - Sale+OE | $9.51 | -342 | 3,754 | -8% | -$3,252 | |||||
| D | 2023-08-08 | EVLO | McHale Duncan | Chief Medical Officer | S - Sale+OE | $9.51 | -3,434 | 7,941 | -30% | -$32,657 | |||||
| D | 2023-08-08 | EVLO | Thorell Marella | CFO | S - Sale+OE | $9.51 | -2,004 | 9,069 | -18% | -$19,058 | |||||
2023-07-11 | EVLO | Flagship Ventures Fund IV General Partner LLC | 10% | P - Purchase | $2.31 | +5,411,255 | 7,932,624 | +215% | +$12,499,999 | ||||||
2023-05-23 | EVLO | Bodmer Mark | CSO, Pres of R, D | S - Sale | $0.14 | -22,571 | 262,557 | -8% | -$3,201 | ||||||
2023-05-08 | EVLO | McHale Duncan | Chief Medical Officer | S - Sale | $0.13 | -66,730 | 97,516 | -41% | -$8,375 | ||||||
2023-05-08 | EVLO | Bodmer Mark | CSO, Pres of R, D | S - Sale | $0.13 | -68,014 | 285,128 | -19% | -$8,536 | ||||||
2023-05-08 | EVLO | Thorell Marella | CFO | S - Sale | $0.13 | -38,531 | 91,469 | -30% | -$4,836 | ||||||
2023-05-08 | EVLO | Gill Simba | Pres, CEO | S - Sale | $0.13 | -3,537 | 58,512 | -6% | -$444 | ||||||
| D | 2023-01-23 | EVLO | Carriere Stephen J | Principal Accounting Officer | S - Sale+OE | $1.06 | -151 | 203 | -43% | -$160 | |||||
2022-05-27 | EVLO | Flagship Ventures Fund IV General Partner LLC | 10% | P - Purchase | $1.46 | +27,397,259 | 50,427,328 | +119% | +$39,999,998 | ||||||
2022-05-27 | EVLO | McHale Duncan | Chief Medical Officer | P - Purchase | $1.46 | +34,246 | 34,246 | New | +$49,999 | ||||||
2022-05-27 | EVLO | Darzi Lord Ara | Dir | P - Purchase | $1.46 | +342,465 | 342,465 | New | +$499,999 | ||||||
2022-05-27 | EVLO | Epstein David R | Dir | P - Purchase | $1.46 | +17,123 | 84,080 | +26% | +$25,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |